The pharmacokinetics of valacyclovir in immunocompromised children.

被引：0
|
作者：
Bomgaars, L
Duran, C
Khan, S
Berg, S
Blaney, S
机构：
[1] Baylor Coll Med, Pediat Pharmacol Res Unit, Houston, TX 77030 USA
[2] Baylor Coll Med, Texas Childrens Canc Ctr, Houston, TX 77030 USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2001年 / 69卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：P15 / P15
页数：1
相关论文
共 50 条
  • [1] Valacyclovir and acyclovir pharmacokinetics in immunocompromised children
    Bomgaars, Lisa
    Thompson, Patrick
    Berg, Stacey
    Serabe, Baruti
    Aleksic, Alek
    Blaney, Susan
    PEDIATRIC BLOOD & CANCER, 2008, 51 (04) : 504 - 508
  • [2] An investigation of the steady-state pharmacokinetics of oral valacyclovir in immunocompromised children
    Nadal, D
    Leverger, G
    Sokal, EM
    Floret, D
    Perel, Y
    Leibundgut, K
    Weller, S
    JOURNAL OF INFECTIOUS DISEASES, 2002, 186 : S123 - S130
  • [3] Nosocomial infections in immunocompromised children.
    Tabone, MD
    Thien, HV
    Moissenet, D
    Leverger, G
    PATHOLOGIE BIOLOGIE, 2000, 48 (10): : 893 - 900
  • [4] Pharmacokinetics of pleconaril in children.
    Kearns, GL
    Wells, TW
    Blowey, DL
    Jackson, MA
    Burry, VF
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1998, 63 (02) : 193 - 193
  • [5] Pharmacokinetics of rifapentine in children.
    Blake, MJ
    Abdel-Rahman, SM
    Jacobs, RF
    Lowery, NK
    Kearns, GL
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2005, 77 (02) : P30 - P30
  • [6] Pharmacokinetics of rofecoxib in children.
    Edwards, J
    Prescilla, RP
    Fratarelli, DA
    Haritos, D
    Aranda, JV
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2004, 75 (02) : P73 - P73
  • [7] Buspirone pharmacokinetics in autistic children.
    Edwards, D
    Chugani, DC
    Chugani, HT
    Chehab, J
    Malian, M
    Aranda, JV
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2005, 77 (02) : P31 - P31
  • [8] Population pharmacokinetics of abacavir in children.
    Jullien, V
    Urien, S
    Chappuy, H
    Dimet, J
    Rey, E
    Pons, G
    Blanche, S
    Treluyer, J
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2005, 77 (02) : P59 - P59
  • [9] Ketorolac pharmacokinetics and metabolism in children.
    Kauffman, RE
    LiehLai, MW
    Uv, H
    Simpson, P
    Danjin, M
    PEDIATRIC RESEARCH, 1996, 39 (04) : 433 - 433
  • [10] Interstitial pneumonitis caused by Ureaplasma urealyticum in immunocompromised children.
    Buckingham, SC
    Crouse, DT
    Park, VM
    Dubray-Benstein, BL
    Patrick, CC
    JOURNAL OF INVESTIGATIVE MEDICINE, 1999, 47 (02) : 150A - 150A
12345